3+ mon, 1+ week ago   (510+ words) The Poison Pill defends against no legitimate threat; 3D's acquisition of additional shares is not aimed at seizing management control, nor does it impair corporate value or the common interests of shareholders. The Board lacks the sufficient independence required to…...

3+ mon, 1+ week ago   (255+ words) At the Choose France summit, Stallergenes Greer, a leading player in the treatment of allergies, announced a strategic investment in its Antony site (Hauts-de-Seine), strengthening its longstanding industrial presence in France. ANTONY, France--(BUSINESS WIRE)--At the 9th Choose France summit,…...

3+ mon, 2+ week ago   (126+ words) If you suffered substantial losses and wish to serve as lead plaintiff of the Medpace class action lawsuit, please provide your information here: You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via…...

3+ mon, 3+ week ago   (346+ words) Analysis demonstrates a lower cost per sustained responder and cystectomy avoided with ANKTIVA plus BCG compared to TAR-200 in Medicare population over three years Cost reductions were primarily driven by lower drug acquisition and administration costs, based on complete response…...

3+ mon, 3+ week ago   (301+ words) Commvault Systems, Inc. faces securities fraud allegations after it failed to achieve projected net new ARR growth due to the ARR mix shift it was experiencing, leading to a stock drop of 31%; investors urged to act by July 17, 2026. NEW YORK…...

3+ mon, 3+ week ago   (978+ words) Five issued U.S. patents cover the combination of ImmunityBio’s IL-15 receptor agonist (NAI) with Bacillus Calmette-Guérin (BCG) for non-muscle invasive bladder cancer treatment, with terms extending through at least 2035Claims cover methods of treating non-muscle invasive bladder cancer (NMIBC) including BCG-naïve disease,…...

3+ mon, 3+ week ago   (568+ words) NEW YORK--(BUSINESS WIRE)--Clarion Partners, LLC (“Clarion”), a leading real estate investment manager and partially owned subsidiary of Franklin Templeton, has announced that it has recently executed on more than a dozen highly curated single-asset healthcare investments totaling over…...

3+ mon, 4+ week ago   (385+ words) “For more than 70 years, Japan BCG Laboratory has been dedicated to the development and manufacture of high-quality BCG products,” said Seiichi Inoue, President of Japan BCG Laboratory. “We are pleased to partner with ImmunityBio to bring the Tokyo strain of…...

3+ mon, 4+ week ago   (403+ words) NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026. Phreesia describes itself as a company…...

4+ mon, 2+ day ago   (515+ words) SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern…...